TotalMarketCap

ADARx Pharmaceuticals

ADRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.087 B

$19.54 -2.01%

Close of 2 Oct 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #94Prestige Consumer HealthcarePBH$2.12B
  2. #95Mineralys TherapeuticsMLYS$2.10B
  3. #96ADARx PharmaceuticalsADRX$2.09B
  4. #97Structure TherapeuticsGPCR$2.07B
  5. #98Trevi TherapeuticsTRVI$2.02B

What if ADARx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.8T

$269,762.14

Per share 13,806× higher

Bitcoin $1.70T

$15,921.35

Per share 815× higher

Nvidia $5.56T

$52,094.17

Per share 2,666× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for ADARx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 3 Oct 2026. Read the methodology.